Filtered By:
Countries: Germany Health

This page shows you your search results in order of date. This is page number 2.

Order by Relevance | Date

Total 445 results found since Jan 2013.

Principles of allergy diagnostics
Z Rheumatol. 2023 Apr 5. doi: 10.1007/s00393-023-01343-4. Online ahead of print.ABSTRACTBACKGROUND: Allergies are frequent and approximately 30% of the general population in Germany are affected. The specific sensitization against an allergen is asymptomatic. On renewed allergen contact the symptoms are indicative of the underlying pathomechanism. A variety of different test procedures are available to identify allergic reactions.OBJECTIVE AND AIM: In this review article the typical clinical symptoms of allergic reactions are assigned to mechanisms and possible test methods are presented and discussed. Current developments...
Source: Zeitschrift fur Rheumatologie - April 5, 2023 Category: Rheumatology Authors: Ulrich Seidl Guido Heine Source Type: research

Limited Reimbursement and Underuse of Digital Healthcare Concepts Are Major Barriers to Clinical Allergological Care in Germany
Conclusion: In conclusion, we have identified several structural barriers to allergological care in Germany. Reimbursement and the use of digital healthcare concepts in German clinics providing allergological care need improvement. Based on the results of this study, there is an urgent need for researchers and policymakers to further investigate and support allergology departments in their clinical work and in their implementation of digital healthcare concepts.Int Arch Allergy Immunol
Source: International Archives of Allergy and Immunology - April 4, 2023 Category: Allergy & Immunology Source Type: research

Cutaneous reactions following COVID-19 vaccination assessed by dermatologists: a single-institutional study in Germany
CONCLUSIONS: It can be assumed that vaccination may trigger immune activation-related reactions especially in those patients predisposed to develop respective skin diseases.PMID:36892192 | DOI:10.1111/ddg.14987
Source: Herpes - March 9, 2023 Category: Infectious Diseases Authors: Rosi Wang Sonja Mathes Carla Claussen Tilo Biedermann Knut Brockow Source Type: research

Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma
Conclusion Ecleralimab significantly attenuated allergen-induced bronchoconstriction and airway inflammation, and was safe in subjects with mild atopic asthma.
Source: European Respiratory Journal - March 9, 2023 Category: Respiratory Medicine Authors: Gauvreau, G. M., Hohlfeld, J. M., FitzGerald, J. M., Boulet, L.-P., Cockcroft, D. W., Davis, B. E., Korn, S., Kornmann, O., Leigh, R., Mayers, I., Watz, H., Grant, S. S., Jain, M., Cabanski, M., Pertel, P. E., Jones, I., Lecot, J. R., Cao, H., O'Byrne, P. Tags: Asthma and allergy Original Articles: Asthma Source Type: research